Patient-Derived Cancer Organoid Cultures to Predict Sensitivity to Chemotherapy and Radiation

Abstract

These studies add to the literature demonstrating feasibility to grow clinical patient-derived organotypic cultures for treatment effectiveness testing. Together, these culture methods and response assessment techniques hold great promise to predict treatment sensitivity for patients with cancer undergoing chemotherapy and/or radiation.